Subscribe To
novartis (nvs) gets fda nod for vijoice in rare disorder
The FDA approves novartis' (NVS) Vijoice (alpelisib) for the treatment of select patients with PIK3CA-r...
April 6, 2022, 1:33 pm
Changes at novartis aimed at boosting shareholder value
novartis ( NVS , Financial) investors hope the organizational changes the company is making can shake l...
April 5, 2022, 10:16 am
novartis integrates pharmaceuticals and oncology, targets savings of $1 billion
novartis said on Monday it was integrating its pharmaceuticals and oncology units into an innovative me...
April 4, 2022, 1:19 am
novartis (nvs) beovu gets label expansion for dme in eu
novartis (NVS) ophthalmology drug Beovus label gets expanded in EU for diabetic macular edema....
April 1, 2022, 10:32 am
novartis (nvs) gets positive chmp opinion for jakafi, kymriah
novartis (NVS) obtains positive CHMP opinion for the label expansion of Jakafi and Kymriah....
March 28, 2022, 3:03 pm
novartis suspends some business activities in russia
Swiss drugmaker novartis said on Tuesday it was suspending capital investments, media advertising, and ...
March 22, 2022, 3:37 am
Pfizer and novartis are betting on this under-the-radar biotech. should you?
Voyager Therapeutics has promising technology. But the stock is very risky....
March 19, 2022, 6:05 am
novartis: exceedingly stable swiss pharma
novartis: Exceedingly Stable Swiss Pharma...
March 14, 2022, 9:27 pm
novartis's data reinforces age-appropriate development with zolgensma gene therapy study
novartis AG (NYSE: NVS) announced new data from the completed Phase 3 SPR1NT study of Zolgensma (ona...
March 14, 2022, 1:00 pm
Voyager (vygr) gains on deal with novartis for gene therapies
Voyager (VYGR) stock rises on the license option agreement with novartis to get a target-specific acces...
March 9, 2022, 2:18 pm
Voyager, novartis sign deal worth up to $1.7 billion
Voyager Therapeutics Inc.'s VYGR, +6.22% stock gained 16.8% in premarket trading on Tuesday after the gene therapy company said it inked a deal with <...
March 8, 2022, 8:30 am
Key fda decisions soon on akebia, bristol-myers and novartis drugs
Do Food and Drug Administration decisions—thumbs up or thumbs down—affect the stock prices of companies seeking drug approvals? We're likely to fi...
March 7, 2022, 6:17 pm
Sanofi-regeneron's dupixent falls short in chronic spontaneous urticaria trial
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have reported disappointing results from the Phase 3 trial of Dupixent (...
February 18, 2022, 7:11 am
Sanofi-regeneron's dupixent falls short in chronic spontaneous urticaria trial
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have reported disappointing results from the Phase 3 trial of Dupixent (...
February 18, 2022, 7:11 am
Sanofi-regeneron's dupixent falls short in chronic spontaneous urticaria trial
Sanofi SA (NASDAQ: SNY) and Regeneron Pharmaceuticals Inc (NASDAQ: REGN) have reported disappointing results from the Phase 3 trial of Dupixent (...
February 18, 2022, 7:11 am
novartis is one of the best high-yield dividend aristocrats you can buy in 2022
novartis Is One Of The Best High-Yield Dividend Aristocrats You Can Buy In 2022...
February 18, 2022, 3:27 am
novartis is one of the best high-yield dividend aristocrats you can buy in 2022
novartis Is One Of The Best High-Yield Dividend Aristocrats You Can Buy In 2022...
February 18, 2022, 3:27 am
novartis is one of the best high-yield dividend aristocrats you can buy in 2022
novartis Is One Of The Best High-Yield Dividend Aristocrats You Can Buy In 2022...
February 18, 2022, 3:27 am
Should value investors consider novartis (nvs) stock now?
Let's see if novartis (NVS) stock is a good choice for value-oriented investors right now from multiple...
February 17, 2022, 4:39 am
Should value investors consider novartis (nvs) stock now?
Let's see if novartis (NVS) stock is a good choice for value-oriented investors right now from multiple...
February 17, 2022, 4:39 am